1. Home
  2. TARS vs NN Comparison

TARS vs NN Comparison

Compare TARS & NN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • NN
  • Stock Information
  • Founded
  • TARS 2016
  • NN 2007
  • Country
  • TARS United States
  • NN United States
  • Employees
  • TARS N/A
  • NN N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • NN Industrial Machinery/Components
  • Sector
  • TARS Health Care
  • NN Industrials
  • Exchange
  • TARS Nasdaq
  • NN Nasdaq
  • Market Cap
  • TARS 2.1B
  • NN 2.2B
  • IPO Year
  • TARS 2020
  • NN N/A
  • Fundamental
  • Price
  • TARS $46.52
  • NN $12.99
  • Analyst Decision
  • TARS Strong Buy
  • NN
  • Analyst Count
  • TARS 5
  • NN 0
  • Target Price
  • TARS $54.20
  • NN N/A
  • AVG Volume (30 Days)
  • TARS 735.2K
  • NN 1.8M
  • Earning Date
  • TARS 02-25-2025
  • NN 03-12-2025
  • Dividend Yield
  • TARS N/A
  • NN N/A
  • EPS Growth
  • TARS N/A
  • NN N/A
  • EPS
  • TARS N/A
  • NN N/A
  • Revenue
  • TARS $129,621,000.00
  • NN $4,963,000.00
  • Revenue This Year
  • TARS $917.88
  • NN $46.32
  • Revenue Next Year
  • TARS $78.70
  • NN $43.50
  • P/E Ratio
  • TARS N/A
  • NN N/A
  • Revenue Growth
  • TARS 801.96
  • NN 43.44
  • 52 Week Low
  • TARS $20.08
  • NN $3.55
  • 52 Week High
  • TARS $57.14
  • NN $18.54
  • Technical
  • Relative Strength Index (RSI)
  • TARS 37.06
  • NN 40.15
  • Support Level
  • TARS $43.61
  • NN $12.33
  • Resistance Level
  • TARS $57.00
  • NN $13.48
  • Average True Range (ATR)
  • TARS 2.65
  • NN 1.31
  • MACD
  • TARS -1.27
  • NN -0.28
  • Stochastic Oscillator
  • TARS 21.51
  • NN 33.38

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About NN NextNav Inc.

NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation and Timing services in the absence of GPS.

Share on Social Networks: